Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Skinvisible (SKVI) Receivables - Net (2016 - 2025)

Skinvisible (SKVI) has disclosed Receivables - Net for 15 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Net changed 0.0% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $5000.0 for FY2025, 0.0% changed from the prior year.
  • Receivables - Net hit $5000.0 in Q4 2025 for Skinvisible, roughly flat from $5000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $6500.0 in Q1 2021 to a low of $82.0 in Q4 2021.
  • Historically, Receivables - Net has averaged $4462.8 across 5 years, with a median of $5000.0 in 2022.
  • Biggest five-year swings in Receivables - Net: plummeted 98.94% in 2021 and later soared 5997.56% in 2022.
  • Year by year, Receivables - Net stood at $82.0 in 2021, then skyrocketed by 5997.56% to $5000.0 in 2022, then changed by 0.0% to $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Business Quant data shows Receivables - Net for SKVI at $5000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.